Amneal Pharmaceuticals Inc Class A (AMRX)
Cost of Revenue
$1.89B
TTM · Period ending: · USD
AMRX Cost of Revenue
Latest reported$1.89Bperiod ending
Latest reported$1.89Bperiod ending
AMRX TTM Cost of Revenue ($513.64M → $1.89B)
TTM cost of revenue
High-resolution chart · PNG
AMRX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,891,763,000 | |
| 1,868,329,000 | |
| 1,905,452,000 | |
| 1,855,968,000 | |
| 1,778,339,000 | |
| 1,791,917,000 | |
| 1,773,519,000 | |
| 1,697,374,000 | |
| 1,651,973,000 | |
| 1,579,165,000 | |
| 1,537,388,000 | |
| 1,540,259,000 | |
| 1,504,077,000 | |
| 1,483,888,000 | |
| 1,427,596,000 | |
| 1,403,719,000 | |
| 1,382,474,000 | |
| 1,346,215,000 | |
| 1,324,696,000 | |
| 1,297,164,000 | |
| 1,352,791,000 | |
| 1,350,639,000 | |
| 1,364,130,000 | |
| 1,308,262,000 | |
| 1,246,402,000 | |
| 1,225,370,000 | |
| 1,273,376,000 | |
| 1,290,402,000 | |
| 1,242,935,000 | |
| 1,179,034,000 | |
| 946,588,000 | |
| 784,421,000 | |
| 627,759,000 | |
| 528,405,000 | |
| 513,643,000 | |
| 493,616,000 |